Defining drug/drug class refractoriness vs lines of therapy in relapsed/refractory multiple myeloma

Blood Cancer Journal, Published online: 11 January 2023; doi:10.1038/s41408-023-00785-yDefining drug/drug class refractoriness vs lines of therapy in relapsed/refractory multiple myeloma

Source: Blood Cancer Journal - January 11, 2023 Category: Hematology Authors: Utkarsh Goel Charalampos Charalampous Prashant Kapoor Moritz Binder Francis K. Buadi David Dingli Angela Dispenzieri Amie Fonder Morie A. Gertz Wilson I. Gonsalves Suzanne R. Hayman Miriam A. Hobbs Yi L. Hwa Taxiarchis Kourelis Martha Q. Lacy Nelson Leung Source Type: research